Columbia, MD, announced that an independent, peer reviewed, clinical research study in which the level of cellular immune response measured prior to kidney transplantation using its proprietary ImmuKnow immune cell function test was found to identify patients that may be at risk for early acute transplant rejection and unstable kidney function in the first three months following transplantation.

Cylex says a statistically significant correlation was reported between high pre-transplant levels of cellular immune response, as measured using ImmuKnow immune cell function test, and early acute transplant rejection as well as unstable kidney function within the first 90 days following kidney transplantation.

today announced the publication of an independent, peer reviewed, clinical research study in which the level of cellular immune response measured prior to kidney transplantation using the Company's proprietary ImmuKnow(R) immune cell function test was found to identify patients that may be at risk for early acute transplant rejection and unstable kidney function in the first three months following transplantation.

A phase I/II study of BTI-322 for the treatment of acute transplant rejection is currently underway at the Massachusetts General Hospital (MGH) under an Investigational New Drug (IND) application submitted by BioTransplant.

The Phase I/II study is designed to assess the tolerability and potential efficacy of BTI-322 in kidney transplant patients experiencing their first episode of biopsy-proven, acute transplant rejection.

We also expanded clinical trials of Oncolysin S, for the treatment of small-cell lung cancer, into Europe, and filed with the Food and Drug Administration to begin human testing of Oncolysin CD6, for the prevention of acute transplant rejection.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.